AquaBounty Technologies (AQB) | Q1 2017 | 3,077,677.78% |
GT Biopharma (GTBP) | Q1 2017 | 1,689,552.17% |
Viewbix Inc Common Stock (VBIX) | Q1 2017 | 91,100% |
SurgePays (SURG) | Q1 2017 | 1,680.36% |
Pulmatrix (PULM) | Q1 2017 | 523.21% |
Duos Technologies (DUOT) | Q1 2017 | 499.63% |
Wetouch Technology Inc Common Stock (WETH) | Q1 2017 | 471.43% |
Castellum (CTM) | Q1 2017 | 431.58% |
Aurinia Pharmaceuticals (AUPH) | Q1 2017 | 242.99% |
Opus Genetics (IRD) | Q1 2017 | 240% |
Medicus Pharma Ltd Common Stock (MDCX) | Q1 2017 | 233.33% |
Pulse Biosciences (PLSE) | Q1 2017 | 214% |
OLB (OLB) | Q1 2017 | 200% |
Talos Energy (TALO) | Q1 2017 | 186.78% |
Protalix Biotherapeutics (PLX) | Q1 2017 | 183.27% |
Esperion Therapeutics (ESPR) | Q1 2017 | 175.86% |
TSS, Inc Common Stock (TSSI) | Q1 2017 | 175% |
Quoin Pharmaceuticals Ltd DRC (QNRX) | Q1 2017 | 169.59% |
Sow Good Inc Common Stock (SOWG) | Q1 2017 | 150% |
authID (AUID) | Q1 2017 | 150% |
RTB Digital (RTB) | Q1 2017 | 150% |
TG Therapeutics (TGTX) | Q1 2017 | 142.71% |
Sanara Medtech (SMTI) | Q1 2017 | 139.47% |
Galectin Therapeutics (GALT) | Q1 2017 | 137.11% |
Applied Opt (AAOI) | Q1 2017 | 136.82% |
